Venlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressant that compounding pharmacies prepare as oral capsules and liquids in individualized strengths.
Venlafaxine is an SNRI. It raises serotonin and norepinephrine in the brain by blocking their reuptake, acting mostly on serotonin at lower doses and on both at higher doses. Its major active metabolite is O-desmethylvenlafaxine. Manufactured products include Effexor XR extended-release capsules (Viatris) and generic immediate-release tablets, extended-release capsules and extended-release tablets. Effexor XR is FDA-approved for adults with major depressive disorder, generalized anxiety disorder, social anxiety disorder and panic disorder; it is not approved for children. Prescribers may order venlafaxine compounded when a patient needs a strength below or between manufactured ones for a slow taper, an oral liquid, or a capsule free of a specific dye or filler. Compounded preparations are not FDA-approved and require a prescription.
Venlafaxine carries the FDA boxed warning "Suicidal Thoughts and Behaviors": antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents and young adults, so watch for worsening mood or thoughts of self-harm, especially early in treatment and after dose changes. Do not take it with an MAOI, linezolid or intravenous methylene blue, or within 14 days of stopping an MAOI, and wait at least 7 days after stopping venlafaxine before starting an MAOI. Venlafaxine can raise blood pressure and heart rate, and the label also warns of serotonin syndrome, bleeding, angle-closure glaucoma, mania, seizures, low sodium, lung inflammation and sexual dysfunction. Stopping abruptly can cause dizziness, nausea and electric-shock sensations, so doses are tapered. Third-trimester use can cause temporary newborn adaptation problems, and later-pregnancy exposure has been linked to preeclampsia and postpartum hemorrhage. Venlafaxine and its metabolite pass into breast milk; serious infant effects are rare, but watch newborns for sedation. If side effects are severe or persist, talk to your prescriber or pharmacist.
Venlafaxine inhibits neuronal serotonin and norepinephrine reuptake, with serotonergic effects predominant at lower doses and noradrenergic effects added at higher doses; the label states the mechanism in MDD, GAD, SAD and PD is unclear but thought to relate to potentiation of both monoamines in the CNS. Absorption is about 92 percent with bioavailability near 45 percent; protein binding is low at 27 to 30 percent; CYP2D6 forms the active metabolite O-desmethylvenlafaxine, CYP3A inhibitors raise levels of both, and venlafaxine itself raises exposure to CYP2D6 substrates; immediate-release half-life is about 5 hours for venlafaxine and about 11 hours for O-desmethylvenlafaxine, steady state is reached within 3 days, and the label calls for dose reduction in renal and hepatic impairment. Labeled indications (Effexor XR, Viatris, revised 8/2023): MDD, GAD, SAD and panic disorder in adults. Prescribers have ordered venlafaxine off-label for vasomotor hot flashes, diabetic neuropathy and other pain syndromes, migraine prophylaxis, PTSD, OCD and PMDD (StatPearls; MedlinePlus lists hot flashes); compounded low-strength capsules and liquids let them individualize titration and tapers. Dosing per prescriber. Monitoring: blood pressure and heart rate, suicidality and mood, sodium, bleeding risk, and depression scales such as PHQ-9 or MADRS. Venlafaxine is not a controlled substance (label section 9.1).
Compounded at Bayview
Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.
For prescribers
Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.